Don Melnikoff is a customer-focused senior leader who excels at team-building and driving strategic growth by aligning company innovation with customer needs.
With a proven track record of strategic transformative growth, Don has successfully built and led teams in small to midsize companies across a range of industries. He has held senior leadership roles and has extensive experience in business development, operations, product development and innovation creation. Don's technical background, specifically in the medical, dental, and biopharma markets, has enabled him to establish new markets, identify growth opportunities, and form strong business alliances.
Mike Reilly’s career comprises over three decades of executive experience in the medical products industry. He advanced within the world’s largest medical products company from Product Director to VP/GM of a major worldwide franchise. In addition, he was brought in by separate investor groups to restage and manage two medical start-up companies. Mike has consulted with several medical products companies.
Mr. Reilly has negotiated the purchase and sale of various size businesses. He holds two patents in the emerging area of interventional pulmonology.
Mike has an M.M. from the Northwestern University Kellogg School of Management and a B.A. in Economics from Rutgers College.
Dr. Audi is a Professor in the Joint Marquette University-Medical College of Wisconsin Department of Biomedical Engineering with expertise in computational modeling, pulmonary metabolism and hemodynamics, and acute lung injury. He is the principal investigator of the Computational Lung Physiology Laboratory, which develops experimental and computational strategies to investigate lung physiology at all levels—from molecular, to cellular, to whole-organ and body. The laboratory’s goal is to identify mechanisms and processes involved in lung diseases and injuries such as sepsis and acute respiratory distress syndrome, and then develop treatments for these diseases that target the elucidated mechanisms.
Dr. Audi’s research interests include acute lung injury, acute respiratory distress syndrome (ARDS), lung transplantation, pulmonary endothelium metabolism, pulmonary hemodynamics, computational modeling, and functional imaging (SPECT, optical). He has been an NIH funded investigator for more than twenty-two years. Dr. Audi has utilized Vivid’s technology to assess varying degrees of lung damage, which may be incorporated into his work involving isolated perfused lung studies.